A New Allergy Vaccine Could Finally Let Anyone Become a Cat Person

February 11, 2020

Cat people, cheers: A new vaccine is being developed that aims to dramatically reduce the symptoms brought on by allergies to furry felines. This isn’t just good news for everyone who wants to curl up with a pack of kittens; it’s even better news for cats themselves.

Despite all the #caturday photos we scroll through on Instagram every day, allergies are still one of the leading causes of cat abandonment worldwide. Having a product like this available to cat parents not only means fewer animals are abandoned, but more animals can find the perfect furever home with parents who don’t sniffle, sneeze or scratch at rashes all day long.

“Of the 3.4 million cats abandoned to U.S. cat shelters each year, approximately 1.4 million animals are euthanized,” HypoPet, the Swiss company behind the potential vaccine, reported in a statement.

Basically, this could be huge. Here’s how it works.

After conducting clinical trials on more than 50 cats, the scientists at HypoPet decided that vaccinating cats would allow them to produce higher levels of antibodies that would reduce the effects of allergies. The main culprit in cat allergies is a protein called Fel d 1, which according to HypoPet is “secreted into saliva and tears and found in the fur” and affects about 85% of people who show symptoms.

Dog owners, gird your loins, because you may be on the verge of being outnumbered.

The vaccine has all sorts of benefits, including reducing the risk of childhood asthma in kittens that live with children.

Dr. Gary Jennings, CEO of HypoPet AG, says the HypoCat vaccine will hopefully be available in the U.S. soon. When that happens, dogs everywhere will have to wait.